Yeesoo Chae

13PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersHaematological tumoursImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 28, 2026
Immune-Related Adverse Events in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy with Pembrolizumab: What Needs to Be Managed Before Surgery.

Jeeyeon Lee, Byeongju Kang, Joon Suk Moon

|Mar 28, 2026
EDIL3/Del-1-Dependent Induction of AMPKβ Phosphorylation Regulates the Progression of Mesenchymal Stem-like Triple-Negative Breast Cancer.

Seol-Hwa Jeong, Soo Jung Lee, In Hee Lee

|Jan 10, 2026
Ten-Year Follow-Up of Mammography and Ultrasonography for Detection of Locoregional Breast Cancer Recurrence in Asian Female Patients.

Joon Suk Moon, In Hee Lee, Byeongju Kang

|Sep 27, 2025
Differential Expression of Long Non-Coding RNA IGF2-AS in Tamoxifen-Resistant Breast Cancer Cells.

Jeeyeon Lee, Byeongju Kang, Eun Ae Kim

|Apr 23, 2024
Exploring the effect of BRCA1/2 status on chemotherapy-induced hematologic toxicity in patients with ovarian cancer.

In Hee Lee, Soo Jung Lee, Juhyung Kim

|Dec 07, 2023
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.

Peter Schmid, Nicholas C Turner, Carlos H Barrios

Pageof 3

Frequent Collaborators

9 joint publications

Soo Jung Lee

7 joint publications

Jeeyeon Lee

5 joint publications

Ho Yong Park

5 joint publications

Byeongju Kang